Literature DB >> 18197366

Preparation and characterization of honokiol nanoparticles.

Ma Ling Gou1, Mei Dai, Xing Yi Li, Xian Huo Wang, Chang Yang Gong, Yao Xie, Ke Wang, Xia Zhao, Zhi Yong Qian, Yu Quan Wei.   

Abstract

In this paper, honokiol nanoparticles were prepared by emulsion solvent evaporation method. The prepared honokiol nanoparticles were characterized by particle size distribution, morphology, zeta potential and crystallography. Results showed that the obtained honokiol nanoparticles at size of 33 nm might be amorphous, and could be well dispersed in water. Due to the great dispersibility in water, the obtained honokiol nanoparticles might have great potential in medical field.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18197366     DOI： 10.1007/s10856-007-3361-6

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN： 0957-4530            Impact factor:   3.896


  16 in total

1.  Drug delivery systems: entering the mainstream.

Authors:  Theresa M Allen; Pieter R Cullis
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

Review 2.  Novel formulations of taxanes: a review. Old wine in a new bottle?

Authors:  K L Hennenfent; R Govindan
Journal:  Ann Oncol       Date:  2005-12-19       Impact factor: 32.976

Review 3.  Nanosizing--oral formulation development and biopharmaceutical evaluation.

Authors:  Filippos Kesisoglou; Santipharp Panmai; Yunhui Wu
Journal:  Adv Drug Deliv Rev       Date:  2007-05-25       Impact factor: 15.470

4.  The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.

Authors:  Traci E Battle; Jack Arbiser; David A Frank
Journal:  Blood       Date:  2005-03-31       Impact factor: 22.113

5.  Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.

Authors:  Kwang Seok Ahn; Gautam Sethi; Shishir Shishodia; Bokyung Sung; Jack L Arbiser; Bharat B Aggarwal
Journal:  Mol Cancer Res       Date:  2006-09       Impact factor: 5.852

6.  Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.

Authors:  Kenji Ishitsuka; Teru Hideshima; Makoto Hamasaki; Noopur Raje; Shaji Kumar; Hiromasa Hideshima; Norihiko Shiraishi; Hiroshi Yasui; Aldo M Roccaro; Paul Richardson; Klaus Podar; Steven Le Gouill; Dharminder Chauhan; Kazuo Tamura; Jack Arbiser; Kenneth C Anderson
Journal:  Blood       Date:  2005-05-03       Impact factor: 22.113

Review 7.  Pluronic block copolymers for overcoming drug resistance in cancer.

Authors:  Alexander V Kabanov; Elena V Batrakova; Valery Yu Alakhov
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

8.  Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo.

Authors:  Xianhe Bai; Francesca Cerimele; Masuko Ushio-Fukai; Muhammad Waqas; Paul M Campbell; Baskaran Govindarajan; Channing J Der; Traci Battle; David A Frank; Keqiang Ye; Emma Murad; Wolfgang Dubiel; Gerald Soff; Jack L Arbiser
Journal:  J Biol Chem       Date:  2003-06-19       Impact factor: 5.157

9.  Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore.

Authors:  Ling Li; Weidong Han; Ying Gu; Shuang Qiu; Qinghua Lu; Jie Jin; Jianhong Luo; Xun Hu
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

10.  Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography.

Authors:  Lijuan Chen; Qiang Zhang; Guangli Yang; Linyu Fan; James Tang; Ian Garrard; Svetlana Ignatova; Derek Fisher; Ian A Sutherland
Journal:  J Chromatogr A       Date:  2007-01-12       Impact factor: 4.759
View more
  5 in total

1.  Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles.

Authors:  MaLing Gou; XiuLing Zheng; Ke Men; Juan Zhang; BiLan Wang; Lei Lv; XiuHong Wang; YinLan Zhao; Feng Luo; LiJuan Chen; Xia Zhao; YuQuan Wei; ZhiYong Qian
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

Review 2.  PCL-PEG copolymer based injectable thermosensitive hydrogels.

Authors:  Mithun Rajendra Dethe; Prabakaran A; Hafiz Ahmed; Mukta Agrawal; Upal Roy; Amit Alexander
Journal:  J Control Release       Date:  2022-01-25       Impact factor: 11.467

3.  In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer.

Authors:  Chang Yang Gong; Shuai Shi; Peng Wei Dong; Xiu Ling Zheng; Shao Zhi Fu; Gang Guo; Jing Liang Yang; Yu Quan Wei; Zhi Yong Qian
Journal:  BMC Biotechnol       Date:  2009-02-11       Impact factor: 2.563

Review 4.  Formulation of Poloxamers for Drug Delivery.

Authors:  Andrew M Bodratti; Paschalis Alexandridis
Journal:  J Funct Biomater       Date:  2018-01-18

5.  Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells.

Authors:  Weiwei Wu; Li Wang; Lingling Wang; Yuangang Zu; Siying Wang; Peiyan Liu; Xiuhua Zhao
Journal:  Int J Nanomedicine       Date:  2018-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.